NCT06614140 2026-04-22Personalized Neoantigen Cancer Vaccine for Patients With Solid TumorsSeqker Biosciences, Inc.Phase 1/2 Completed8 enrolled
NCT03223103 2025-09-10Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat GlioblastomaAlbert Einstein College of MedicinePhase 1 Active not recruiting13 enrolled